Group 1: Magnesium Production Methods - The main method used domestically for magnesium production is the silicon thermal reduction method, which has a simpler process and lower investment costs [1] - The electrolytic method, which produces magnesium and chlorine gas from anhydrous magnesium chloride, is more complex and requires higher investment; however, companies are working to overcome technical challenges and reduce production costs [1] Group 2: Resource Availability - The company’s subsidiary, Chaohu Baomei, has a dolomite resource reserve of 90 million tons, currently in operation [2] - Another subsidiary, Wutai Baomei, has a dolomite resource reserve of 580 million tons, while the affiliated company Anhui Baomei holds 1.3 billion tons, which is not yet in production [2] - The ample mineral resources ensure stable raw material supply for magnesium and magnesium alloy production, laying a foundation for the company's full magnesium industry chain development [2] Group 3: Magnesium Alloy Applications - Magnesium alloy building templates are lightweight, have excellent surface release effects, and significant cost advantages; the company has improved surface treatment processes and reduced production costs [3] - The current application ratio of magnesium-aluminum building templates is 50% each, with positive feedback from customers, especially frontline workers [3] - The company has begun exporting magnesium alloy templates and is gradually developing the Southeast Asian market [3] Group 4: Automotive Industry Penetration - Magnesium prices have remained lower than aluminum prices, accelerating the penetration of magnesium in automotive lightweighting [4] - Die-casting factories are increasingly adopting magnesium die-casting, with many aluminum die-casting manufacturers expanding into magnesium [4] - Some automotive companies are using over 20 kg of magnesium alloy products per vehicle, with potential future usage reaching 50-100 kg as larger magnesium die-cast parts are integrated [4] Group 5: Strontium Products - Strontium is a rare alkaline earth metal that can enhance the strength, hardness, and corrosion resistance of alloys when added to aluminum and magnesium [5] - The company has an annual production capacity of 3,000 tons of metallic strontium, with an estimated annual output of about 2,500 tons [5]

Group 1 - The city has added 125 new "little giant" enterprises and 16 national manufacturing single champions, showcasing significant progress in industrial development [1] - The city's industrial value added increased by 6.2% year-on-year in the first three quarters, with 28 out of 37 major industry categories showing growth [1] - The software industry in the city achieved over 750 billion yuan in revenue, growing by 16.4% year-on-year, moving towards a trillion-level market [2] Group 2 - The collaboration between Jiangsu Jianmi Intelligent Technology Co., Ltd. and China Mobile Jiangsu aims to innovate in robotics and communication technology, driving the smart and digital transformation of the industry [3] - Key industries such as new-generation information communication, smart grids, and integrated circuits have all seen double-digit growth [4] Group 3 - The city has organized over 130 market expansion activities to promote product-market alignment and collaboration across the industrial chain [6] - Nanjing Weili Zhibo Biotechnology Co., Ltd. has a pipeline of 12 innovative drug candidates, with 6 in clinical stages, showcasing strong R&D capabilities [6] Group 4 - The city has hosted 24 events under the "Thousand Schools and Ten Thousand Enterprises" initiative to facilitate technology transfer from universities to specialized enterprises [7] - Key manufacturing sectors such as electrical machinery, general equipment, and pharmaceuticals have shown strong growth, with respective increases of 8.0%, 9.5%, 11.6%, 9.6%, and 10.0% [7] Group 5 - The 10th China Advanced Materials Industry Expo highlighted local enterprises, with significant investment intentions amounting to nearly 2 billion yuan [8] - Nanjing has cultivated 47 national manufacturing single champion enterprises, ranking seventh nationally, and 459 "little giant" enterprises, ranking ninth [9] - The city is expected to add more national-level intelligent factories this year, enhancing the overall capability of its manufacturing sector [9]

Core Insights - The demand for medical magnesium oxide is steadily increasing due to the aging global population and rising disease incidence, with the market size in China projected to reach 652 million yuan in 2024, a year-on-year increase of 12.7% [1][8]. Industry Overview - Magnesium oxide (MgO) is an inorganic compound widely used in the pharmaceutical industry as an antacid, laxative, and magnesium supplement for treating conditions like gastritis, gastric ulcers, constipation, and magnesium deficiency [1][4]. - The quality standards for pharmaceutical excipients in China's medical industry are continuously improving, leading to broader recognition and application of medical magnesium oxide in new drug formulations [1][8]. Industry Chain - The upstream of the medical magnesium oxide industry includes raw materials such as dolomite and magnesite, which are abundant in China, ensuring a stable supply for production [6][7]. - The midstream involves the production of medical magnesium oxide, while the downstream focuses on its applications in the pharmaceutical sector [6]. Market Dynamics - The production capacity of magnesium oxide in China is expected to reach 24.38 million tons in 2024, with a year-on-year increase of 3.7%, and the demand is projected to reach 21.78 million tons, up 4.5% [8]. - The industry is primarily dominated by small to medium-sized enterprises, with high-purity pharmaceutical-grade magnesium oxide production technology still not fully scaled [10][11]. Competitive Landscape - Domestic companies are enhancing their competitiveness through technological breakthroughs and supply chain integration, focusing on high-end product development [11]. - Key players in the medical magnesium oxide sector include Hebei Magnesium Technology Co., Ltd., Hebei Baisite Pharmaceutical Co., Ltd., and others, with some companies pioneering unique production processes [11][12]. Development Trends - Technological innovation is expected to drive the industry forward, with new production techniques improving the purity and quality of medical magnesium oxide while reducing costs [12]. - The industry is also moving towards greener and more sustainable practices, necessitating increased investment in environmental protection and advanced equipment [13][14].

Core Viewpoint - Baowu Magnesium Industry (002182) announced that as of the date of the announcement, the company and its subsidiaries have no overdue external guarantees and are not involved in any litigation related to external guarantees or any losses due to guarantee judgments [1] Summary by Categories - **Company Status** - Baowu Magnesium Industry has confirmed that there are no overdue external guarantees [1] - The company and its subsidiaries are not involved in any litigation concerning external guarantees [1] - There are no losses incurred from guarantee judgments against the company [1]

Core Viewpoint - Baowu Magnesium Industry announced that as of the date of the announcement, the total amount of external guarantees provided by the company is approximately 407 million yuan, which accounts for 7.63% of the audited net assets attributable to shareholders of the listed company as of the end of 2024 [1] Summary by Relevant Sections - External Guarantees - The cumulative external guarantees provided by the company, excluding the current guarantee, amount to approximately 407 million yuan [1] - The current balance of external guarantees is 91.12 million yuan, which is specifically for the guarantee to Yian Yunhai, accounting for 1.71% of the audited net assets attributable to shareholders of the listed company as of the end of 2024 [1]

证券代码：002182 证券简称：宝武镁业 公告编号：2025-47 根据公司《关于拟公开挂牌转让参股子公司巢湖宜安云海科技有限公司 40% 股权的公告》，公司已决定转让所持宜安云海的股权，股权转让的同时实现担保 责任转移，由股权受让方承接担保责任。公司担保期限至宜安云海股权转让日或 股权转让日前担保责任退出日为止。 本次关联担保事项尚需提交公司股东会审议。 宝武镁业科技股份有限公司 关于为参股子公司巢湖宜安云海科技有限公司 提供担保暨关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 2025 年 10 月 24 日，宝武镁业科技股份有限公司（以下简称"宝武镁业" 或"公司"）召开第七届董事会第十一次会议审议通过了《关于拟公开挂牌转让 参股子公司巢湖宜安云海科技有限公司 40%股权的议案》，拟转让持有参股子公 司巢湖宜安云海科技有限公司（以下简称"宜安云海"）40%股权。 为保证参股子公司宜安云海股权转让之前生产经营所需周转资金，同时鉴于 宜安云海部分银行授信额度到期需进行续贷，公司于 2025 年 10 月 31 日召开第 七届董事 ...

证券代码：002182 证券简称：宝武镁业 公告编号：2025-48 宝武镁业科技股份有限公司 关于召开 2025 年第四次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2025 年第四次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上市 规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等法 律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。 4、会议时间： （1）现场会议时间：2025 年 11 月 17 日 14:00:00 互联网投票系统参加网络投票的股东。 8、会议地点：南京市溧水区东屏街道开屏路 11 号，四楼会议室。 二、会议审议事项 1、本次股东会提案编码表 | 提案编码 | 提案名称 | | 备注 | | --- | --- | --- | --- | | | | 提案类型 | 该列打勾的栏目可以 | | | | | 投票 | | 100 | 总议案：除累积投票提案外的所有提案 | ...

第七届董事会第十二次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 宝武镁业科技股份有限公司（以下简称"宝武镁业"或"公司"）第七届董 事会第十二次会议于 2025 年 10 月 31 日以通讯形式召开，会议通知已于 2025 年 10 月 27 日以书面及电子邮件方式通知全体董事及高级管理人员，并通过电话确 认。会议应到董事 11 人，实到董事 11 人。公司高级管理人员列席了会议。会议 召开符合法律、法规及《公司章程》的相关规定。 会议由董事长孔祥宏先生主持，出席会议的董事以电子通讯表决方式审议并 通过了如下议案： 证券代码：002182 证券简称：宝武镁业 公告编号：2025-49 宝武镁业科技股份有限公司 一、审议通过了《关于为参股子公司巢湖宜安云海科技有限公司提供担保暨 关联交易的议案》 为保证参股子公司宜安云海股权转让之前生产经营所需周转资金，同时鉴于 宜安云海部分银行授信额度到期需进行续贷，参股子公司宜安云海拟向相关金融 机构申请担保融资，融资授信额度不超过人民币 24,780.00 万元，公司持有宜安 云海 40.00%的股权，即 ...

Core Points - The company announced that its seventh board meeting will be held on October 31, 2025, to review two proposals [1] - The first proposal involves providing a guarantee for its associate company, Chaohu Yian Yunhai Technology Co., Ltd., which plans to apply for financing not exceeding 24,780,000 yuan, with the company holding a 40% stake and a guarantee amount of 9,912,000 yuan [1] - The second proposal is to convene the fourth extraordinary general meeting of shareholders on November 17, 2025 [1]

Core Viewpoint - The company plans to transfer a 40% stake in its associate subsidiary, Yian Yunhai, and is seeking a guarantee financing of up to 248 million yuan to ensure liquidity before the transfer [1] Group 1: Share Transfer and Financing - The company intends to transfer a 40% stake in Yian Yunhai [1] - Yian Yunhai aims to apply for guarantee financing not exceeding 248 million yuan [1] - The company will provide a guarantee amounting to 99.12 million yuan, which represents 1.86% of the audited net assets as of the end of 2024 [1] Group 2: Related Transactions and Guarantees - The guarantee period will last until the date of the share transfer or the exit date of the guarantee responsibility, with the assignee assuming the responsibility [1] - From early 2025 to the disclosure date, the company has engaged in related transactions totaling 125 million yuan with Yian Yunhai [1] - As of the disclosure date, the company has provided a total of 407 million yuan in external guarantees, with no overdue guarantees reported [1]